Registry for Advanced Sarcodiosis | NCT03769987 | Trialant
Unknown statusObservationalUpdated Dec 10, 2018
Registry for Advanced Sarcodiosis
Registry for Advanced Sarcoidosis
ClinicalTrials.gov ID
NCT03769987
Lead Sponsor
University of CincinnatiOTHER
Overall Status
Unknown status
Study Type
Observational
Enrollment
800Estimated
Last Update Posted
Dec 10, 2018Actual
Start Date
Jan 1, 2017Actual
Primary Completion Date
Dec 31, 2019Estimated
Completion Date
Jun 30, 2020Estimated
Official Title
Registry for Advanced Sarcoidosis
Brief Summary
Registry with evaluation and genetic information of patients with advanced sarcoidosis and matched sarcoidosis
Sarcoidosis
observation
Ages Eligible for Study
Child (0-17)Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria
Patients with diagnosis of sarcoidosis based on ATS/WASOG criteria 22
Age ≥ 18 years.
Life expectancy of at least 2 years.
Pulmonary function tests (spirometry) within one month of entry or willing to under pulmonary function testing on the day of study enrollment
Sarcoidosis as characterized as either advanced or non-advanced (see protocol for definition of advanced disease)
Subjects must be able to understand and be willing to sign the written informed consent form. A signed informed consent form must be appropriately obtained prior to the conduct of any trial-specific procedure.
Exclusion criteria
Subjects with a medical disorder, condition, or history of such that would impair the subject's ability to participate or complete this study in the opinion of the investigator
Inability to comply with the protocol and/or not willing or not available for follow-up assessments.
Any condition which, in the investigator's opinion, makes the subject unsuitable for trial participation.